Cargando…
Epithelial–mesenchymal transition in organ fibrosis development: current understanding and treatment strategies
Organ fibrosis is a process in which cellular homeostasis is disrupted and extracellular matrix is excessively deposited. Fibrosis can lead to vital organ failure and there are no effective treatments yet. Although epithelial–mesenchymal transition (EMT) may be one of the key cellular mechanisms, th...
Autores principales: | Liu, Lexin, Sun, Qizhe, Davis, Frank, Mao, Jianhua, Zhao, Hailin, Ma, Daqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990740/ https://www.ncbi.nlm.nih.gov/pubmed/35402628 http://dx.doi.org/10.1093/burnst/tkac011 |
Ejemplares similares
-
Pretreatment with valproic acid alleviates pulmonary fibrosis through epithelial–mesenchymal transition inhibition in vitro and in vivo
por: Chen, Lin, et al.
Publicado: (2021) -
Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
por: Lovisa, Sara
Publicado: (2021) -
Lens Fibrosis: Understanding the Dynamics of Cell Adhesion Signaling in Lens Epithelial-Mesenchymal Transition
por: Taiyab, Aftab, et al.
Publicado: (2022) -
Involvement of epithelial–mesenchymal transition in liver fibrosis
por: Yu, Kangkang, et al.
Publicado: (2018) -
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype
por: Fabris, Luca, et al.
Publicado: (2016)